Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 10:19 PM
NCT ID:
NCT01169558
Group ID:
EG000
Title:
Bevacizumab
Description:
Bevacizumab (5 mg/kg intravenously every 2 weeks or 7.5 mg/kg intravenously every 3 weeks) was administered in combination with fluoropyrimidine-based chemotherapy as first line treatment in participants with metastatic cancer of the colon or rectum until disease progression or study completion.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
50
Serious Number At Risk:
162
Other Number Affected:
153
Other Number At Risk:
162
Study:
NCT01169558
Results Section:
NCT01169558
Adverse Events Module:
NCT01169558